2021. COVID-19 in tralokinumab-treated patients with moderate-to- severe atopic dermatitis: case series from the ECZTEND long- term extension trial. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s58. DOI:https://doi.org/10.25251/skin.5.supp.58.